Literature DB >> 1149788

Immune complex deposits in systemic lupus erythematosus kidney without histological or functional alterations.

A Cruchaud, F Chenais, G J Fournié, L Humair, P H Lambert, J C Mulli, F Chatelanat.   

Abstract

This study demonstrates that in systemic lupus erythematosus (SLE), the presence of immune complexes on the glomerular basement membrane (GEM) does not invariabley result in histological and/or functional lesions of the kidney. Among a group of 29 lupus patients, six subjects were selected for thorough investigation, because their renal function was normal or only slightly altered though they had suffered from SLE for 20 months to 18 years. All patients had antinuclear factor, anti-native-DNA antibody and a low level of complement; 3 had anti-denatured-DNA antibody, 2 had denatured DNA-anti-denatured-DNA circulating complexes and 3 had anti-RNA-protein antibody. Kidney biopsies disclosed either no histological lesion or minimal changes in five of them and diffuse proliferative glomerulonephritis in one. By contrast, using the immunofluorescent technique, granular deposits containing the third component of complement (C3) were found on the GBM of all patients; IgG was present in 5 cases, IgM in 3, fibrinogen in two cases and around the tubules of one. Electron microscopy confirmed the presence of subendothelial and mesangial deposits. Our results also showed a good correlation between the importance of deposits and the presence of denatured DNA-anti-denatured-DNA circulating complexes. From the data obtained in these 6 cases as well as in the 23 other patients of the group, 3 categories of lupus patients could be distinguished with regard to kidney involvement: 1) patients with insignificant histological lesions, no immune deposits and essentially normal function; 2) patients with definite histological lesions, immune deposits and renal insufficiency and 3) patients with few if any histological lesions and little functional impairment contrasting with important immune deposits. The resistance of some patients to the mephrotoxic effects of immune deposits shows that lupus nephritis depends on intricate pathogenic mechanisms and suggests that these are possible antagonized by "protective" factors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1149788     DOI: 10.1111/j.1365-2362.1975.tb00458.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.

Authors:  J S Cameron; M H Lessof; C S Ogg; B D Williams; D G Williams
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

2.  The proteins of the aqueous humour.

Authors:  J P Dernouchamps
Journal:  Doc Ophthalmol       Date:  1982-11-01       Impact factor: 2.379

3.  The value of three immune complex assays in the management of systemic lupus erythematosus: an assessment of immune complex levels, size and immunochemical properties in relation to disease activity and manifestations.

Authors:  S A Cairns; A London; N P Mallick
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

4.  Systemic lupus erythematosus without clinical renal abnormalities: renal biopsy findings and clinical course.

Authors:  J R O'Dell; R C Hays; S J Guggenheim; J C Steigerwald
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

5.  Clearing the complexity: immune complexes and their treatment in lupus nephritis.

Authors:  Catherine Toong; Stephen Adelstein; Tri Giang Phan
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-01-11

6.  Long-term Outcome of Lupus Nephritis Class II in Argentine Patients: An Open Retrospective Analysis.

Authors:  Maria Victoria Collado; Enrique Dorado; Silvia Rausch; Graciela Gomez; Marina Khoury; Federico Zazzetti; María Gargiulo; Lorena Suarez; Rafael Chaparro; Sergio Paira; Laura Galvan; Vicente Juarez; Cecilia Pisoni; Mercedes Garcia; Liliana Martinez; Analia Alvarez; Clarisa Alvarez; Juan Barreira; Judith Sarano
Journal:  J Clin Rheumatol       Date:  2016-09       Impact factor: 3.517

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.